Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Children's Hospital, Westmead, Australia
Research from Australia, the United States and the United Kingdom in diabetes provides new insights
September 13th, 2006
Reports from Australia, the United States and the United Kingdom highlight recent research in diabetes. Study 1: Metformin therapy for obese insulin-resistant pediatric patients improved body composition and fasting insulin. According to a study from Australia, "Metformin therapy for adults and children with type 2 diabetes is well established. However, its role in the treatment of insulin resistance and obesity in children and adolescents is less clearly defined. We assessed the effect of metformin on body composition and insulin sensitivity in pediatric subjects with exogenous obesity. Patients referred to a pediatric endocrine clinic were enrolled...
Source: Telemedicine Business Week (2006-09-13)
|
